Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product-Reference-Cited by-同舟云学术

Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product

Published:2011-01-13 Issue:3 Volume:6 Page:229-233
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Hasegawa Makoto¹,Miura Tatsuhiro¹,Kuzuya Kouji¹,Inoue Ayu¹,Won Ki Se²,Horinouchi Sueharu²,Yoshida Tetsuo³,Kunoh Tatsuki¹,Koseki Koichi¹,Mino Koshiki¹,Sasaki Ryuzo¹,Yoshida Minoru⁴,Mizukami Tamio¹

Affiliation:

1. Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan

2. Department of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan

3. Innovative Drug Research Laboratories, Kyowa Hakko Kirin Co. Ltd., Machida, Tokyo 194-8533, Japan

4. Chemical Genetics Laboratory, RIKEN, Wako, Saitama 351-0198, Japan

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cb100248e

Reference19 articles.

1. GEX1 Compounds, Novel Antitumor Antibiotics Related to Herboxidiene, Produced by Streptomyces sp. I. Taxonomy, Production, Isolation, Physicochemical Properties and Biological Activities.

2. GEX1 Compounds, Novel Antitumor Antibiotics Related to Herboxidiene, Produced by Streptomyces sp. II. The Effects on Cell Cycle Progression and Gene Expression.

3. p21 and p27: roles in carcinogenesis and drug resistance

4. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA

5. Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A defective splicing machinery promotes senescence through MDM4 alternative splicing;Aging Cell;2024-08-08

2. Inhibition of SF3B1 affects recruitment of P-TEFb to chromatin through multiple mechanisms;2024-06-27

3. Alternative splicing in prostate cancer progression and therapeutic resistance;Oncogene;2024-04-24

4. Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition;Marine Drugs;2024-03-23

5. Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain;RNA;2023-11-28